All resources are organized into categories. Click the arrow to reveal the subcategories within each category. Click any category or subcategory to view all the resources it contains.
Text search
Enter words or phrases to search for resources. Note: This searches on the resource titles and descriptions, but does not currently search the content of the resources (e.g., the text in a PDF).
Advanced Search
Tick the boxes to search any combination of category, resource format, author, publication date, and whether a resource is peer reviewed or available in French. As you check and uncheck items, the count of matching resources will update. Click the blue “SHOW RESULTS” button to view resources that match the criteria you have selected.
This DMPA-SC Advocacy Pack brief describes key evidence-building efforts, advocacy actions, and policy changes in Uganda brought about by key partners to increase access to injectable contraception, including DMPA-SC. You can draw on lessons learned from Uganda to inform your policy goals and advocacy strategy for increasing method choice and access with DMPA-SC and self-injection in your country.
This DMPA-SC Advocacy Pack brief summarizes important takeaways for advocates based on World Health Organization guidance on hormonal contraception, including DMPA injectables, and HIV for women at high risk of HIV.
This DMPA-SC Advocacy Pack brief details the strong body of evidence and experience with self-injection of DMPA-SC, including how the practice can reduce access-related barriers, improve contraceptive continuation, and enhance women’s autonomy.
This DMPA-SC Advocacy Pack brief packages accurate, evidence-based messages about the features and benefits of DMPA-SC and how the product can increase women’s access to contraception.
This DMPA-SC Advocacy Pack brief offers quick facts on the benefits of DMPA-SC; the product’s potential for empowering women and adolescent girls; the product’s availability; and how subcutaneous DMPA is different from intramuscular DMPA (DMPA-IM).
These DMPA-SC Advocacy Pack briefs outline existing evidence on DMPA-SC grouped into top-line messages featuring data from different countries. Several “spotlight” handouts on specific topics can be paired with the summary brief as needed. All handouts can be printed and distributed directly to decision-makers.
Using simple messages, this DMPA-SC Advocacy Pack case statement describes reasons why DMPA-SC is a valuable and game-changing addition to a broad contraceptive method mix.
This DMPA-SC Advocacy Pack brief summarizes recent evidence from African countries on the costs and cost-effectiveness of DMPA-SC. Key findings include that DMPA-SC may help reduce service delivery costs by catalyzing expansion of channels closest to women and that self-injected DMPA-SC is cost-saving as compared to clinic-administered DMPA-IM when accounting for costs to women and health systems.
This DMPA-SC Advocacy Pack brief offers concise, evidence-based information to help answer common questions and dispel myths about injectable contraception.
